Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Dividends Score | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $4.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| TGTX | TG THERAPEUTICS INC | $2.15B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| GMAB | GENMAB A | $18.14B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| INCY | INCYTE CORP | $11.49B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.50B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.64B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CORT | CORCEPT THERAPEUTICS INC | $2.30B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| MDXG | MIMEDX GROUP INC | $917.76M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| HALO | HALOZYME THERAPEUTICS INC | $4.88B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| RPRX | ROYALTY PHARMA PLC | $16.79B | 1.42% | 23.60% | $0.2000 | $0.40 | 28% | 0 | |||
| VNDA | VANDA PHARMACEUTICALS INC | $257.77M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| TECH | BIO-TECHNE CORP | $9.85B | 0.51% | 22.70% | $0.0800 | $0.32 | 8% | 1 | |||
| EXEL | EXELIXIS INC | $7.13B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.70B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| PBYI | PUMA BIOTECHNOLOGY INC | $235.25M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| BNTX | BIONTECH SE | $20.61B | N/A | 0.00% | $2.1110 | N/A | N/A | 0 | |||
| AMLX | AMYLYX PHARMACEUTICALS INC | $120.65M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.73B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| NVO | NOVO NORDISK A S | $567.31B | 1.09% | 38.10% | $0.9299 | $1.37 | 20% | 8 | |||
| UTHR | UNITED THERAPEUTICS CORP | $11.10B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| REGN | REGENERON PHARMACEUTICALS INC | $97.76B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $102.73B | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.